Cutler Group LP Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 26, 2021	SELL	$1.27 - $3.42 $1,270 - $3,420	-1,000 Reduced 90.91%	100 $0
Q4 2020 Jan 21, 2021	SELL	$0.94 - $1.89 $14,100 - $28,350	-15,000 Reduced 93.17%	1,100 $0
Q3 2020 Oct 27, 2020	BUY	$1.5 - $9.38 $24,150 - $151,018	16,100 New	16,100 $0
Q1 2019 May 10, 2019	SELL	$5.76 - $8.95 $71,424 - $110,979	-12,400 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$5.26 - $7.97 $12,098 - $18,331	-2,300 Reduced 15.65%	12,400 $1,000
Q3 2018 Nov 07, 2018	BUY	$4.65 - $7.95 $68,355 - $116,865	14,700 New	14,700 $21,000
Q2 2018 Aug 10, 2018	SELL	$5.05 - $6.8 $4,545 - $6,120	-900 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$6.6 - $7.78 $52,800 - $62,240	-8,000 Reduced 89.89%	900 $0
Q3 2017 Oct 17, 2017	BUY	$5.75 - $7.75 $51,175 - $68,975	8,900	8,900 $3,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.62B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.